Patent details
EP1267848 Title: DOSING REGIMEN COMPRISING A FARNESYL PROTEIN TRANSFERASE INHIBITOR FOR THE TREATMENT OF CANCER
Basic Information
- Publication number:
- EP1267848
- PCT Application Number:
- PCT/EP/2001/001937
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP019037852
- PCT Publication Number:
- WO/2001/062234
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- DOSING REGIMEN COMPRISING A FARNESYL PROTEIN TRANSFERASE INHIBITOR FOR THE TREATMENT OF CANCER
- French Title of Invention:
- REGIME POSOLOGIQUE CONTENANTE INHIBITEURS DE LA FARNESYL PROTEINE TRANSFERASE POUR LE TRAITEMENT DU CANCER
- German Title of Invention:
- DOSIERSCHEMA ENTHALDEND FARNESYL PROTEIN TRANSFERASE INHIBITOREN FÜR DIE BEHANDLUNG VON KREBS
- SPC Number:
Dates
- Filing date:
- 20/02/2001
- Grant date:
- 17/10/2007
- EP Publication Date:
- 17/10/2007
- PCT Publication Date:
- 30/08/2001
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 02/01/2003
- EP B1 Publication Date:
- 17/10/2007
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 20/02/2008
- Expiration date:
- 20/02/2021
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 20/02/2001
- Name:
- JANSSEN PHARMACEUTICA N.V.
- Address:
- Turnhoutseweg 30, 2340 Beerse, Belgium (BE)
Inventor
- Name:
- END David, William
- Address:
- United States (US)
Priority
- Priority Number:
- 184551 P
- Priority Date:
- 24/02/2000
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 31/4704;
| Filing date | Document type | Number of pages |
|---|